Neovacs SA (France) Price History

ALNEV Stock  EUR 0.0002  0.0001  33.33%   
If you're considering investing in Neovacs Stock, it is important to understand the factors that can impact its price. As of today, the current price of Neovacs SA stands at 0.0002, as last reported on the 2nd of December, with the highest price reaching 0.0003 and the lowest price hitting 0.0002 during the day. Neovacs SA appears to be out of control, given 3 months investment horizon. Neovacs SA has Sharpe Ratio of 0.026, which conveys that the firm had a 0.026% return per unit of risk over the last 3 months. By analyzing Neovacs SA's technical indicators, you can evaluate if the expected return of 0.6% is justified by implied risk. Please exercise Neovacs SA's Downside Deviation of 33.7, mean deviation of 12.47, and Risk Adjusted Performance of 0.0208 to check out if our risk estimates are consistent with your expectations.
  
Neovacs Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.026

Best PortfolioBest Equity
Good Returns
Average Returns
Small ReturnsALNEV
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 23.28
  actual daily
96
96% of assets are less volatile

Expected Return

 0.6
  actual daily
11
89% of assets have higher returns

Risk-Adjusted Return

 0.03
  actual daily
2
98% of assets perform better
Based on monthly moving average Neovacs SA is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Neovacs SA by adding it to a well-diversified portfolio.

Neovacs SA Stock Price History Chart

There are several ways to analyze Neovacs Stock price data. The simplest method is using a basic Neovacs candlestick price chart, which shows Neovacs SA price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceSeptember 10, 20248.0E-4
Lowest PriceNovember 26, 20241.0E-4

Neovacs SA December 2, 2024 Stock Price Synopsis

Various analyses of Neovacs SA's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Neovacs Stock. It can be used to describe the percentage change in the price of Neovacs SA from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Neovacs Stock.
Neovacs SA Price Rate Of Daily Change 0.67 
Neovacs SA Price Daily Balance Of Power(1.00)

Neovacs SA December 2, 2024 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Neovacs Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Neovacs SA intraday prices and daily technical indicators to check the level of noise trading in Neovacs Stock and then apply it to test your longer-term investment strategies against Neovacs.

Neovacs Stock Price History Data

The price series of Neovacs SA for the period between Tue, Sep 3, 2024 and Mon, Dec 2, 2024 has a statistical range of 0.0 with a coefficient of variation of 51.97. The prices are distributed with arithmetic mean of 0.0. The median price for the last 90 days is 0.0. The company had 10000:1 stock split on 31st of August 2024.
OpenHighLowCloseVolume
12/02/2024
 0.0003  0.0003  0.0002  0.0002 
11/29/2024 0.0003  0.0003  0.0002  0.0002  16,213,174 
11/28/2024 0.0003  0.0004  0.0002  0.0003  225,630,750 
11/27/2024 0.0002  0.0002  0.0001  0.0002  23,959,503 
11/26/2024 0.0003  0.0003  0.0001  0.0001  56,189,872 
11/25/2024 0.0002  0.0003  0.0002  0.0002  33,103,211 
11/22/2024 0.0002  0.0003  0.0001  0.0002  41,395,223 
11/21/2024 0.0003  0.0003  0.0001  0.0002  52,097,121 
11/20/2024 0.0003  0.0003  0.0001  0.0002  23,364,381 
11/19/2024 0.0002  0.0003  0.0002  0.0002  34,323,953 
11/18/2024 0.0003  0.0003  0.0001  0.0002  43,540,980 
11/15/2024 0.0003  0.0003  0.0001  0.0002  50,392,006 
11/14/2024 0.0002  0.0003  0.0001  0.0002  18,758,170 
11/13/2024 0.0002  0.0003  0.0001  0.0002  39,875,578 
11/12/2024 0.0003  0.0003  0.0002  0.0002  108,404,094 
11/11/2024 0.0002  0.0003  0.0002  0.0002  30,046,061 
11/08/2024 0.0002  0.0003  0.0002  0.0002  16,890,285 
11/07/2024 0.0003  0.0003  0.0002  0.0002  35,058,030 
11/06/2024 0.0002  0.0003  0.0002  0.0002  36,125,761 
11/05/2024 0.0002  0.0003  0.0002  0.0002  31,303,927 
11/04/2024 0.0002  0.0003  0.0002  0.0003  26,063,271 
11/01/2024 0.0003  0.0003  0.0002  0.0002  65,008,331 
10/31/2024 0.0003  0.0004  0.0002  0.0002  44,752,167 
10/30/2024 0.0003  0.0004  0.0002  0.0004  14,050,542 
10/29/2024 0.0003  0.0003  0.0002  0.0003  21,302,292 
10/28/2024 0.0003  0.0004  0.0002  0.0002  55,462,025 
10/25/2024 0.0003  0.0003  0.0003  0.0003  3,461,423 
10/24/2024 0.0003  0.0003  0.0002  0.0003  19,798,902 
10/23/2024 0.0003  0.0003  0.0002  0.0003  23,526,686 
10/22/2024 0.0002  0.0003  0.0002  0.0002  6,211,152 
10/21/2024 0.0003  0.0003  0.0002  0.0002  44,937,289 
10/18/2024 0.0003  0.0003  0.0002  0.0002  12,418,797 
10/17/2024 0.0002  0.0003  0.0002  0.0002  53,174,121 
10/16/2024 0.0003  0.0004  0.0002  0.0002  149,154,452 
10/15/2024 0.0004  0.0004  0.0003  0.0003  8,217,380 
10/14/2024 0.0004  0.0005  0.0003  0.0003  100,082,225 
10/11/2024 0.0005  0.0005  0.0004  0.0004  10,116,954 
10/10/2024 0.0004  0.0005  0.0004  0.0004  21,503,820 
10/09/2024 0.0005  0.0005  0.0004  0.0004  31,601,641 
10/08/2024 0.0006  0.0008  0.0004  0.0004  322,606,716 
10/07/2024 0.0005  0.0006  0.0005  0.0005  8,867,037 
10/04/2024 0.0006  0.0006  0.0005  0.0005  11,462,796 
10/03/2024 0.0006  0.0006  0.0005  0.0005  2,715,081 
10/02/2024 0.0006  0.0006  0.0005  0.0006  16,676,980 
10/01/2024 0.0005  0.0006  0.0005  0.0006  2,983,051 
09/30/2024 0.0006  0.0006  0.0005  0.0006  24,653,131 
09/27/2024 0.0005  0.0006  0.0005  0.0006  21,003,573 
09/26/2024 0.0005  0.0006  0.0005  0.0006  9,356,111 
09/25/2024 0.0006  0.0006  0.0005  0.0006  4,450,996 
09/24/2024 0.0005  0.0006  0.0005  0.0006  4,542,750 
09/23/2024 0.0006  0.0006  0.0005  0.0006  2,512,810 
09/20/2024 0.0007  0.0007  0.0006  0.0006  59,085,195 
09/19/2024 0.0007  0.0007  0.0006  0.0006  29,670,499 
09/18/2024 0.0007  0.0008  0.0006  0.0007  50,020,131 
09/17/2024 0.0006  0.0007  0.0006  0.0006  19,208,641 
09/16/2024 0.0007  0.0007  0.0006  0.0006  12,048,300 
09/13/2024 0.0006  0.0007  0.0005  0.0006  7,079,045 
09/12/2024 0.0006  0.0006  0.0006  0.0006  4,465,300 
09/11/2024 0.0008  0.0008  0.0005  0.0005  79,551,402 
09/10/2024 0.0007  0.0008  0.0006  0.0008  17,044,932 
09/09/2024 0.0007  0.0007  0.0006  0.0007  3,510,002 

About Neovacs SA Stock history

Neovacs SA investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Neovacs is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Neovacs SA will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Neovacs SA stock prices may prove useful in developing a viable investing in Neovacs SA
Neovacs S.A., a biotechnology company, focuses on the development of therapeutic vaccines for the treatment of autoimmune, inflammatory, allergy, and cancer diseases in France. Neovacs S.A. was founded in 1993 and is based in Paris, France. NEOVACS operates under Biotechnology classification in France and is traded on Paris Stock Exchange. It employs 24 people.

Neovacs SA Stock Technical Analysis

Neovacs SA technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Neovacs SA technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Neovacs SA trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Idea Breakdown Now

   

Idea Breakdown

Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
All  Next Launch Module

Neovacs SA Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Neovacs SA's price direction in advance. Along with the technical and fundamental analysis of Neovacs Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Neovacs to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Additional Tools for Neovacs Stock Analysis

When running Neovacs SA's price analysis, check to measure Neovacs SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neovacs SA is operating at the current time. Most of Neovacs SA's value examination focuses on studying past and present price action to predict the probability of Neovacs SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neovacs SA's price. Additionally, you may evaluate how the addition of Neovacs SA to your portfolios can decrease your overall portfolio volatility.